- Home
- SYTA vs ADXN Comparison
SYTA vs ADXN Comparison
Compare SYTA & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- ADXN
- Stock Information
- Founded
- SYTA N/A
- ADXN 2002
- Country
- SYTA Canada
- ADXN Switzerland
- Employees
- SYTA N/A
- ADXN N/A
- Industry
- SYTA Telecommunications Equipment
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- ADXN Health Care
- Exchange
- SYTA Nasdaq
- ADXN Nasdaq
- Market Cap
- SYTA 10.7M
- ADXN 10.1M
- IPO Year
- SYTA 2020
- ADXN N/A
- Fundamental
- Price
- SYTA $4.29
- ADXN $8.83
- Analyst Decision
- SYTA
- ADXN Strong Buy
- Analyst Count
- SYTA 0
- ADXN 1
- Target Price
- SYTA N/A
- ADXN $30.00
- AVG Volume (30 Days)
- SYTA 3.6M
- ADXN 14.4K
- Earning Date
- SYTA 08-15-2025
- ADXN 08-11-2025
- Dividend Yield
- SYTA N/A
- ADXN N/A
- EPS Growth
- SYTA N/A
- ADXN N/A
- EPS
- SYTA N/A
- ADXN 0.10
- Revenue
- SYTA $11,740,024.00
- ADXN $278,508.00
- Revenue This Year
- SYTA $18.41
- ADXN $86.57
- Revenue Next Year
- SYTA N/A
- ADXN N/A
- P/E Ratio
- SYTA N/A
- ADXN $0.78
- Revenue Growth
- SYTA 33.58
- ADXN N/A
- 52 Week Low
- SYTA $0.93
- ADXN $6.51
- 52 Week High
- SYTA $162.90
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- SYTA 62.85
- ADXN 49.41
- Support Level
- SYTA $3.70
- ADXN $8.78
- Resistance Level
- SYTA $4.68
- ADXN $9.89
- Average True Range (ATR)
- SYTA 0.63
- ADXN 0.67
- MACD
- SYTA 0.22
- ADXN -0.03
- Stochastic Oscillator
- SYTA 73.46
- ADXN 43.01
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.